Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Interleukin-2 receptor alpha (IL-2Rα), also known as CD25 or Tac antigen, is a type I transmembrane protein that forms part of the high-affinity interleukin-2 (IL-2) receptor complex on immune cells. It plays a crucial role in regulating immune responses, particularly T cell proliferation and the function of regulatory T cells (Tregs). A soluble form of IL-2Rα (sIL-2Rα) serves as a biomarker for immune system activation.
IL-2Rα binds IL-2, facilitating the formation of the high-affinity IL-2 receptor complex, which then triggers downstream signaling pathways affecting T cell proliferation and function.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Interleukin-2 Receptor Alpha (IL-2Rα).